24.02.2016
- Major drugs firms AstraZeneca, Pfizer and Eli Lilly are among seven of the world’s largest pharmaceutical companies that have joined a new consortium to improve clinical trials for...
19.02.2016
- Major drug makers Roche and AstraZeneca have been granted breakthrough therapy designations (BTD) by the US Food and Drug Administration (FDA) for treatments in multiple sclerosis...
10.02.2016
- The combination of two cancer drugs from UK-Swedish drugs maker AstraZeneca and its biologics research and development arm MedImmune could be a potential breakthrough in treating a...
08.02.2016
- European regulators have approved a lung cancer drug from UK-Swedish drug maker AstraZeneca. Tagrisso was the first new drug to win accelerated approval by the European Medicines...
05.02.2016
- Major drugs companies Johnson & Johnson (J&J) and GlaxoSmithKline (GSK) have become partners in a €210 million life sciences venture capital fund. Both groups will each contribute...
03.02.2016
- A key upcoming industry event is DCAT Week, the flagship event of the Drug, Chemical & Associated Technologies Association (DCAT). DCAT Week brings together pharmaceutical and...
01.02.2016
- The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to UK-Swedish drug maker AstraZeneca for its oral poly ADP-ribose polymerase (PARP)...
29.01.2016
- The US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) submitted by UK-Swedish drugmaker AstraZeneca in partnership with Canadian...
